TY - JOUR
T1 - Spinal Cord Swelling after Surgery in Cervical Spondylotic Myelopathy
T2 - Relationship with Intramedullary Gd-DTPA Enhancement on MRI
AU - Ozawa, Hiroshi
AU - Aizawa, Toshimi
AU - Tateda, Satoshi
AU - Hashimoto, Ko
AU - Kanno, Haruo
AU - Ishizuka, Masato
N1 - Funding Information:
Received for publication February 16, 2018; accepted May 9, 2018. From the *Department of Orthopaedic Surgery, Faculty of Medicine, Tohoku Medical and Pharmaceutical University; and †Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan. Supported by a Japanese Health Labor Sciences Research Grant. The authors declare no conflict of interest. Reprints: Hiroshi Ozawa, MD, Department of Orthopaedic Surgery, Faculty of Medicine Tohoku Medical and Pharmaceutical University, 1-12-1 Fukumuro Miyaginoku, Sendai 983-8512, Japan (e-mail: hozawa@hosp. tohoku-mpu.ac.jp). Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Study Design: This is a prospective multicenter study. Summary of Background Data: Postoperative spinal cord swelling has been reported in patients with cervical spondylotic myelopathy. In the cases of the spinal cord swelling, the involvement in the intramedullary gadoliniumdiethylenetriamine pentaacetic acid (Gd-DTPA) enhancement on magnetic resonance imaging (MRI) was referred. Objective: The prevalence and clinical relevance of postoperative spinal cord swelling and its relationship with intramedullary Gd-DTPA enhancement in patients with cervical spondylotic myelopathy were investigated. Subjects and Methods: A total of 683 consecutive patients with cervical spondylotic myelopathy who underwent laminoplasty were examined. T1, T2, and Gd-DTPA-enhanced MRI were performed before surgery. Patients with intramedullary Gd-DTPA enhancement were allocated to the enhancement group. Fifty consecutive cases who did not exhibit intramedullary Gd-DTPA enhancement were allocated to the nonenhancement group. Both groups underwent MRI examinations at 1 month and 1 year after surgery. Results: The prevalence of spinal cord swelling in the enhancement group (26%) was significantly higher than that in the nonenhancement group (4%) (P=0.0038). At 1 year after surgery, spinal cord swelling had resolved in all patients in the nonenhancement group, while it persisted in 3 of 13 patients (23%) in the enhancement group. On multiple regression analysis, intramedullary Gd-DTPA enhancement rather than the spinal cord swelling showed a significant influence in terms of recovery of the Japanese Orthopedic Association score. Conclusions: Surgical outcomes of patients with postoperative swelling should be evaluated separately according to the presence or absence of intramedullary Gd-DTPA enhancement on MRI. Spinal cord swelling associated with intramedullary Gd-DTPA enhancement was indicative of poor prognosis.
AB - Study Design: This is a prospective multicenter study. Summary of Background Data: Postoperative spinal cord swelling has been reported in patients with cervical spondylotic myelopathy. In the cases of the spinal cord swelling, the involvement in the intramedullary gadoliniumdiethylenetriamine pentaacetic acid (Gd-DTPA) enhancement on magnetic resonance imaging (MRI) was referred. Objective: The prevalence and clinical relevance of postoperative spinal cord swelling and its relationship with intramedullary Gd-DTPA enhancement in patients with cervical spondylotic myelopathy were investigated. Subjects and Methods: A total of 683 consecutive patients with cervical spondylotic myelopathy who underwent laminoplasty were examined. T1, T2, and Gd-DTPA-enhanced MRI were performed before surgery. Patients with intramedullary Gd-DTPA enhancement were allocated to the enhancement group. Fifty consecutive cases who did not exhibit intramedullary Gd-DTPA enhancement were allocated to the nonenhancement group. Both groups underwent MRI examinations at 1 month and 1 year after surgery. Results: The prevalence of spinal cord swelling in the enhancement group (26%) was significantly higher than that in the nonenhancement group (4%) (P=0.0038). At 1 year after surgery, spinal cord swelling had resolved in all patients in the nonenhancement group, while it persisted in 3 of 13 patients (23%) in the enhancement group. On multiple regression analysis, intramedullary Gd-DTPA enhancement rather than the spinal cord swelling showed a significant influence in terms of recovery of the Japanese Orthopedic Association score. Conclusions: Surgical outcomes of patients with postoperative swelling should be evaluated separately according to the presence or absence of intramedullary Gd-DTPA enhancement on MRI. Spinal cord swelling associated with intramedullary Gd-DTPA enhancement was indicative of poor prognosis.
KW - cervical spondylotic myelopathy
KW - gadoliniumdiethylenetriamine pentaacetic acid
KW - magnetic resonance imaging
KW - spinal cord swelling
KW - surgical outcome
UR - http://www.scopus.com/inward/record.url?scp=85048280973&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048280973&partnerID=8YFLogxK
U2 - 10.1097/BSD.0000000000000664
DO - 10.1097/BSD.0000000000000664
M3 - Article
C2 - 29863595
AN - SCOPUS:85048280973
SN - 2380-0186
VL - 31
SP - E363-E367
JO - Clinical Spine Surgery
JF - Clinical Spine Surgery
IS - 7
ER -